Akero Therapeutics (NASDAQ:AKRO) reported its Q3 earnings results on Monday, November 13, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Akero Therapeutics missed estimated earnings by 4.41%, reporting an EPS of $-0.71 versus an estimate of $-0.68.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 6.59% increase in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Akero Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
